UNSPSC 51262401: Procaterol

This classification denotes an adrenergic beta-2 receptor agonist, bronchodilator agent, and sympathomimetic with the molecular formula C16H22N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X7I3EMM5K0, chemically known as 8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1h)-quinolinone (r*,s*)-(+-)- but generally known as procaterol, which bears US NIH Compound Identifier 4916. European Medicines Agency schedules Procaterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10058MIG.

UNSPSC 51262401 Procaterol is a Commodity code whose nominal scope does not align with the recent state and local opportunities tagged under it. The two sourced opportunities center on naloxone procurement and direct-to-manufacturer prescription programs—neither of which involves procaterol, a bronchodilator medication with a narrower clinical application. The code shows little relevant recent activity in state and local procurement under its actual product definition, and the opportunities present appear to be miscategorized at the Commodity level.

The issuing bodies represented in the recent records include Seminole County, Florida (IFB 60459723LAS for naloxone and safe drug deactivation systems, due July 26, 2023) and the Texas Health and Human Services Commission (RFI HHS0017013 for direct-to-manufacturer prescription programs, posted April 3, 2026). The Seminole County solicitation is a competitive IFB for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; vendors must cover shipping costs and comply with drug-free workplace and E-Verify requirements, with a two-year initial term and one-year renewal option. The Texas HHS RFI is an exploratory information-gathering mechanism seeking vendor capabilities for direct contracting between the state pharmacy benefit program and manufacturers, without formal evaluation criteria or budget parameters at this preliminary stage. Neither opportunity is germane to procaterol procurement specifically, suggesting that the code's recent activity either reflects data-entry errors in state or local systems or that state and local jurisdictions are not actively soliciting procaterol under this classification at present.